Ginkgo Bioworks (DNA) completed the first milestone of a partnership with Merck (MRK) focused on improving biologic manufacturing. As part of this milestone completion, Ginkgo will receive a research milestone payment of $9M in cash. The two companies will now move on to the second stage of this partnership, which will be focused on continuing to improve the production process.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.